J&J | JNJ - Biaya Operasional





Biaya Operasional Perubahan Tanggal
AbbVie USD 10.27B 1000K 2026-06
Abbott USD 10.46B 1.15B 2026-06
Amgen USD 11.69B 6.9B 2026-06
AstraZeneca USD 12.22B 4.04B 2026-06
Baxter International USD 2.68B 3.36B 2026-06
Bayer EUR 10.04B 168M 2026-06
Becton, Dickinson and Co. USD 24.42B 283M 2026-06
Biogen USD 2.98B 1.02B 2026-06
Boston Scientific USD 4.2B 49M 2026-06
Bristol-Myers Squibb USD 22.32B 2.25B 2026-06
CONMED USD 307.08M 15.45M 2026-06
Cooper Companies USD 1.11B 301.2M 2026-03
Dexcom USD 990.1M 53.5M 2026-06
Edwards Lifesciences USD 1.22B 87.6M 2026-06
Eli Lilly USD 10.52B 496M 2026-06
Gilead Sciences USD 3.95B 19.57B 2026-06
GlaxoSmithKline GBP 5.8B 468M 2026-06
Globus Medical USD 835.58M 239.73M 2026-06
Insulet USD 672M 32.3M 2026-06
Integra LifeSciences USD 1.04B 971K 2026-06
Intuitive Surgical USD 1.91B 3.6M 2026-06
J&J USD 17.83B 388M 2026-06
Medtronic USD 7.72B 436M 2026-03
Merck USD 15.77B 2.4B 2026-06
Merit Medical Systems USD 358.44M 20.72M 2026-06
Novartis USD 10.2B 912M 2026-06
Pfizer USD 85.19B 4.91B 2026-06
Regeneron Pharmaceuticals USD 31.71B 287.8M 2026-06
Roche Holding CHF 18.9B 2.12B 2026-06
Sanofi EUR 9.92B 607M 2026-06
Stryker USD 4.8B 118M 2026-06
Tandem Diabetes Care USD 268.35M 3.7M 2026-06
Teva Pharmaceutical Industries USD 3.92B 691M 2026-06
Vertex Pharmaceuticals USD 2.07B 217.1M 2026-06
Zimmer Biomet Holdings USD 1.83B 140.7M 2026-06
Zoetis USD 3.15B 85M 2026-06